Skip to main content

Table 3 Outcomes of hematologic oncology and HCT patients requiring rapid response system activation

From: Outcomes of hospitalized hematologic oncology patients receiving rapid response system activation for acute deterioration

Outcomes

All hematologic oncology patients (n = 401)

HCT patients (n = 145)

Mortality, n (%)

168 (41.9)

53 (36.6)

Admit to ICU, n (%)a

145 (45.0)

55 (41.7)

ICU length of stay, days, median (IQR)

5 (1–9)

6 (2–9)

Hospital length of stay, days, median (IQR)

19 (8.5–37)

26.5 (16–47)

Survivors discharged home, n (%)b

154 (76.2)

61 (77.2)

  1. aAnalysis only includes patients with goals of care allowing for ICU admission (hematology oncology: n = 322; HCT: n = 13))
  2. bAnalysis only includes survivors initially from home (hematology oncology: n = 202; HCT: n = 79)
  3. Abbreviations: RRS rapid response system, ICU intensive care unit, IQR interquartile range, CI confidence interval
Back to article page

Critical Care

ISSN: 1364-8535